Disability in moderate chronic obstructive pulmonary disease: Prevalence, burden and assessment-results from a real-life study

Respiration

Volumn 89, Issue 2, 2015, Pages 100-106

  Braido, Fulvio ^a   Baiardini, Ilaria ^a   Scichilone, Nicola ^b   Sorino, Claudio ^b,c   Di Marco, Fabiano ^d   Corsico, Angelo ^f   Santus, Pierachille ^e   Girbino, Giuseppe ^g   Di Maria, Giuseppe ^h   Mereu, Carlo ⁱ   Sabato, Eugenio ^j   Foschino Barbaro, Maria Pia ^k   Cuttitta, Giuseppina ^l   Zolezzi, Alberto ^m   Bucca, Caterina ⁿ   Balestracci, Sara ^a   Canonica, Giorgio Walter ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c Pulmonology Unit   (Italy)

^d Medical School   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITY OF PAVIA   (Italy)

^g UNIVERSITY OF MESSINA   (Italy)

^h UNIVERSITY OF CATANIA   (Italy)

ⁱ SANTA CORONA HOSPITAL   (Italy)

^j Department of Pneumology and Respiratory Rehabilitation 'A Blasi' ^*  (Italy)

^k UNIVERSITY OF FOGGIA   (Italy)

^l INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^m AO Carlo Poma   (Italy)

ⁿ UNIVERSITY OF TURIN   (Italy)

more..

Author keywords

Chronic obstructive pulmonary disease; Disability; Patient reported outcomes

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; MUSCARINIC RECEPTOR BLOCKING AGENT; THEOPHYLLINE;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DEATH; DISABILITY; DISABILITY SEVERITY; DISABLED PERSON; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; LUNG BURDEN; MAJOR CLINICAL STUDY; MALE; MODIFIED MEDICAL RESEARCH COUNCIL SCORE; OXYGEN THERAPY; PATIENT ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING HABIT; WELLBEING; CLINICAL TRIAL; ITALY; MIDDLE AGED; MULTICENTER STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ACTIVITIES OF DAILY LIVING; AGED; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HEALTH STATUS; HUMANS; ITALY; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84924249944     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000368365     Document Type: Article

References (25)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global Strategy for the Diagnosis, Management and Prevention of COPD. www.goldcopd.com/guidelines-global-strategy-for-diagnosis-management.html.
2. Han MK, Muellerova H, Curran-Everett D, Dransfield MT, Washko GR, Regan EA, Bowler RP, Beaty TH, Hokanson JE, Lynch DA, Jones PW, Anzueto A, Martinez FJ, Crapo JD, Silverman EK, Make BJ: GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med 2013; 1: 43-50.
3. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, Curran-Everett D, Silverman EK, Crapo JD: Genetic epidemiology of COPD (COPDGene) study design. COPD 2010; 7: 32-43.
4. Lange P, Marott JL, Vestbo J, Olsen KR, Ingebrigtsen TS, Dahl M, Nordestgaard BG: Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification. Am J Respir Crit Care Med 2012; 186: 975-981.
5. Soriano JB, Alfageme I, Almagro P, Casanova C, Esteban C, Soler-Catalunã JJ, de Torres JP, Martinez-Camblor P, Miravitlles M, Celli BR, Marin JM: Distribution and prognostic validity of the new global initiative for chronic obstructive lung disease grading classification. Chest 2013; 143: 694-702.
6. Johannessen A, Nilsen RM, Storebø M, Gulsvik A, Eagan T, Bakke P: Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization. Am J Respir Crit Care Med 2013; 188: 51-59 .
7. Leivseth L, Brumpton BM, Nilsen TI, Mai XM, Johnsen R, Langhammer A: GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway. Thorax 2013; 68: 914-921.
8. Yohannes AM: Disability in patients with COPD. Chest 2014; 145: 200-202.
9. Braido F, Baiardini I, Menoni S, Bagnasco AM, Balbi F, Bocchibianchi S, Balestracci S, Piroddi MG, Canonica GW: Disability in COPD and its relationship to clinical and patient-reported outcomes. Curr Med Res Opin 2011; 27: 981-986.
10. Atsou K, Chouaid C, Hejblum G: Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review. BMC Med 2011; 18: 7.
11. Troosters T, van der Molen T, Polkey M, Rabinovich RA, Vogiatzis I, Weisman I, Kulich K: Improving physical activity in COPD: towards a new paradigm. Respir Res 2013; 14: 115.
12. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2007. http://www. goldcopd.org/.
13. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force: Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
14. Mahoney FI, Barthel DW: Functional evaluation: the Barthel index. Md State Med J 1965; 14: 61-65.
15. Graf C; Hartford Institute for Geriatric Nursing: The Lawton instrumental activities of daily living (IADL) scale. Medsurg Nurs 2008; 17: 343-344.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
17. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force: Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
18. Moss-Morris R, Weinman J, Petrie K, Horne R, Cameron LD, Buick D: The revised illness perception questionnaire (IPQ-R). Psychol Health 2002; 17: 116.
19. Dupuy HJ: The psychological general wellbeing (PGWB) index; in Wenger NK, Mattson ME, Furberg CD, Elinson J (eds): Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York, Le Jacq Publishing, 1984, pp 170-183.
20. Ware J Jr, Kosinski M, Keller SD: A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-233.
21. Hukkinen M, Korhonen T, Heikkilä K, Kaprio J: Association between smoking behavior patterns and chronic obstructive pulmonary disease: a long-term follow-up study among Finnish adults. Ann Med 2012; 44: 598-606.
22. Rodríguez-Rodríguez P, Jiménez-Garciá R, Hernández-Barrera V, Carrasco-Garrido P, Puente-Maestu L, de Miguel-Diéz J: Prevalence of physical disability in patients with chronic obstructive pulmonary disease and associated risk factors. COPD 2013; 10: 611-617.
23. Janaudis-Ferreira T, Beauchamp MK, Robles PG, Goldstein RS, Brooks D: Measurement of activities of daily living in patients with COPD: a systematic review. Chest 2014; 145: 253-271.
24. Aguilaniu B, Gonzalez-Bermejo J, Regnault A, Barbosa CD, Arnould B, Mueser M, Granet G, Bonnefoy M, Similowski T: Disability Related to COPD Tool (DIRECT): towards an assessment of COPD-related disability in routine practice. Int J Chron Obstruct Pulmon Dis 2011; 6: 387-398.
25. Locke E, Thielke S, Diehr P, Wilsdon AG, Graham Barr R, Hansel N, Kapur VK, Krishnan J, Enright P, Heckbert SR, Kronmal RA, Fan VS: Effects of respiratory and non-respiratory factors on disability among older adults with airway obstruction: the Cardiovascular Health Study. COPD 2013; 10: 588-596.